Trial Profile
Myrbetriq (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 07 May 2019 Status changed from active, no longer recruiting to completed.
- 21 Sep 2018 Planned End Date changed from 1 Aug 2018 to 1 Dec 2018.
- 21 Sep 2018 Planned primary completion date changed from 1 Aug 2018 to 1 Dec 2018.